Nanoparticle–cell membrane interactions

Particle-Lung Interactions, Second Edition

Volumn , Issue , 2009, Pages 226-242

  Rothen Rutishauser, Barbara ^a   Blank, Fabian ^a   Mühlfeld, Christian ^a,b   Gehr, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85070941401     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (108)

1. Donaldson K, Stone V, Tran CL, et al. Nanotoxicology. Occup Environ Med 2004; 61(9): 727-728.
2. Maynard AD, Aitken RJ, Butz T, et al. Safe handling of nanotechnology. Nature 2006; 444 (7117):267-269.
3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113(7):823-839.
4. Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science 2006; 311(5761):622-627.
5. Borm P, Klaessig FC, Landry TD, et al. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol Sci 2006; 90(1):23-32.
6. Pope ICA, Dockery DW, Schwartz J. Review of epidemiological evidence of health effects of particulate air pollution. Inhal Toxicol 1995; 7:1-18.
7. Peters A, Wichmann HE, Tuch T, et al. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997; 155(4):1376-1383.
8. Lighty JS, Veranth JM, Sarofim AF. Combustion aerosols: factors governing their size and composition and implications to human health. J Air Waste Manag Assoc 2000; 50(9): 1565-1618.
9. Schulz H, Harder V, Ibald-Mulli A, et al. Cardiovascular effects of fine and ultrafine particles. J Aerosol Med 2005; 18(1):1-22.
10. Ruckerl R, Greven S, Ljungman P, et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007; 115(7):1072-1080.
11. Borm PJA, Kreyling W. Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 2004; 4(5):521-531.
12. Oberdorster G, Maynard A, Donaldson K, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005; 2:8.
13. Stoeger T, Reinhard C, Takenaka S, et al. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 2006; 114(3):328-333.
14. Duffin R, Tran L, Brown D, et al. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007; 19(10):849-856.
15. Brown DM, Donaldson K, Borm PJ, et al. Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004; 286(2):344-353.
16. Vinzents PS, Moller P, Sorensen M, et al. Personal exposure to ultrafine particles and oxidative DNA damage. Environ Health Perspect 2005; 113(11):1485-1490.
17. Unfried K, Albrecht C, Klotz LO, et al. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 2007; 1:1-20.
18. Muhlfeld C, Rothen-Rutishauser B, Blank F, et al. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 2008; 294(5):L817-L829.
19. Donaldson K, Tran L, Jimenez LA, et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005; 2:10.
20. Wichmann HE, Spix C, Tuch T, et al. Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. Res Rep Health Eff Inst 2000; (98):5-86.
21. Kreyling WG, Semmler M, Erbe F, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002; 65(20):1513-1530.
22. Oberdorster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002; 65(20):1531-1543.
23. Peters A, Veronesi B, Calderon-Garciduenas L, et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol 2006; 3:13.
24. Nicod LP. Lung defenses: an overview. Eur Respir Rev 2005; 95:45-50.
25. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 1978; 32(2):121-140.
26. Gehr P, Schiirch S, Berthiaume Y, et al. Particle retention in airways by surfactant. J Aerosol Med 1990; 3(1):27-43.
27. Gil J, Weibel ER. Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec 1971; 169(2):185-199.
28. Schurch S, Gehr P, Im Hof V, et al. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 1990; 80:17-32.
29. Kilburn KH. A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis 1968; 98(3):449-463.
30. Brain JD. Lung macrophages: how many kinds are there? What do they do? Am Rev Respir Dis 1988; 137(3):507-509.
31. Lehnert BE. Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 1992; 97:17-46.
32. Schneeberger EE, Lynch RD. Tight junctions. Their structure, composition, and function. Circ Res 1984; 55(6):723-733.
33. Godfrey RW. Human airway epithelial tight junctions. Microsc Res Tech 1997; 38(5): 488-499.
34. Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 2007; 36(6):669-677.
35. Jahnsen FL, Strickland DH, Thomas JA, et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol 2006; 177(9):5861-5867.
36. Niess JH, Reinecker HC. Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract. Curr Opin Gastroenterol 2005; 21(6):687-691.
37. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2(4):361-367.
38. Takano K, Kojima T, Go M, et al. HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem 2005; 53(5):611-619.
39. Maina JN, West JB. Thin and strong! The bioengineering dilemma in the structural and functional design of the blood-gas barrier. Physiol Rev 2005; 85(3):811-844.
40. Yurchenco PD, Tsilibary EC, Charonis AS, et al. Models for the self-assembly of basement membrane. J Histochem Cytochem 1986; 34(1):93-102.
41. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91(4):1487-1500.
42. Schneeberger EE. Ultrastructure of intercellular junctions in the freeze fractured alveolarcapillary membrane of mouse lung. Chest 1977; 71(2 suppl):299-300.
43. Geiser M, Schurch S, Gehr P. Influence of surface chemistry and topography of particles on their immersion into the lung’s surface-lining layer. J Appl Physiol 2003; 94(5):1793-1801.
44. Geiser M, Matter M, Maye I, et al. Influence of airspace geometry and surfactant on the retention of man-made vitreous fibers (MMVF 10a). Environ Health Perspect 2003; 111 (7):895-901.
45. Wikstrom ME, Stumbles PA. Mouse respiratory tract dendritic cell subsets and the immunological fate of inhaled antigens. Immunol Cell Biol 2007; 85(3):182-188.
46. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7(9):1678-1689.
47. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol 2004; 31(1):3-7.
48. Holt PG, Stumbles PA. Characterization of dendritic cell populations in the respiratory tract. J Aerosol Med 2000; 13(4):361-367.
49. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 2005; 172(5):530-551.
50. Brain JD, Gehr P, Kavet RI. Airway macrophages. The importance of the fixation method. Am Rev Respir Dis 1984; 129(5):823-826.
51. Geiser M, Baumann M, Cruz-Orive LM, et al. The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters. Am J Respir Cell Mol Biol 1994; 10(6):594-603.
52. Holt PG, Schon-Hegrad MA, McMenamin PG. Dendritic cells in the respiratory tract. Int Rev Immunol 1990; 6(2-3):139-149.
53. Nicod LP. Function of human lung dendritic cells. In: Lipscomb MF, Stephen WR, eds. Lung Macrophages and Dendritic Cells in Health Disease. New York: Marcel Dekker, Inc., 1997: 311-334.
54. Holt PG, Schon-Hegrad MA. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 1987; 62(3): 349-356.
55. McWilliam AS, Holt PG, Gehr P. Dendritic cells as sentinels of immune surveillance in the airways. In: Gehr P, Heyder J, eds. Particle-Lung Interactions. New York, Basel: Marcel Dekker, 2000:473-489.
56. Rothen-Rutishauser B, Muhlfeld C, Blank F, et al. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol 2007; 4:9.
57. Muhlfeld C, Mayhew TM, Gehr P, et al. A novel quantitative method for analyzing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med 2007; 20(4):395-407.
58. Nemmar A, Hoet PH, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105(4):411-414.
59. Mills NL, Amin N, Robinson SD, et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 2006; 173(4):426-431.
60. Wiebert P, Sanchez-Crespo A, Falk R, et al. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 2006; 18(10):741-747.
61. Michiels C. Endothelial cell functions. J Cell Physiol 2003; 196(3):430-443.
62. Meiring JJ, Borm PJ, Bagate K, et al. The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol 2005; 2:3.
63. Brown JS, Zeman KL, Bennett WD. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 2002; 166(9):1240-1247.
64. Oberdorster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16(6-7):437-445.
65. Elder A, Gelein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006; 114(8):1172-1178.
66. Ghio AJ, Bennett WD. Metal particles are inappropriate for testing a postulate of extrapulmonary transport. Environ Health Perspect 2007; 115(2):A70-A71.
67. Daniels CB, Orgeig S. Pulmonary surfactant: the key to the evolution of air breathing. News Physiol Sci 2003; 18:151-157.
68. Gerber PJ, Lehmann C, Gehr P, et al. Wetting and spreading of a surfactant film on solid particles: influence of sharp edges and surface irregularities. Langmuir 2006; 22(12): 5273-5281.
69. Erpenbeck VJ, Malherbe DC, Sommer S, et al. Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol 2005; 288(4):L692-L698.
70. Kendall M. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 2007; 293(4):L1053-L1058.
71. Bakshi MS, Zhao L, Smith R, et al. Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J 2008; 94(3):855-868.
72. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1972; 175(23):720-731.
73. Eisenberg D, Schwarz E, Komaromy M, et al. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol 1984; 179(1):125-142.
74. Warren G, Wickner W. Organelle inheritance. Cell 1996; 84(3):395-400.
75. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422 (6927):37-44.
76. Muhlfeld C, Gehr P, Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 2008; 138(2728):387-391.
77. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623.
78. Brzoska M, Langer K, Coester C, et al. Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun 2004; 318(2): 562-570.
79. Foster KA, Yazdanian M, Audus KL. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol 2001; 53(1):57-66.
80. Stearns RC, Paulauskis JD, Godleski JJ. Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol 2001; 24(2):108-115.
81. Kato T, Yashiro T, Murata Y, et al. Evidence that exogenous substances can be phag-ocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res 2003; 311(1):47-51.
82. Geiser M, Casaulta M, Kupferschmid B, et al. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 2008; 38(3): 371-376.
83. Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005; 113(11):1555-1560.
84. Lesniak W, Bielinska AU, Sun K, et al. Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 2005; 5(11):2123-2130.
85. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106(3):255-258.
86. Kiss AL, Kittel A. Early endocytotic steps in elicited macrophages: omega-shaped plasma membrane vesicles at their cell surface. Cell Biol Int 1995; 19(6):527-538.
87. Kiss AL, Geuze HJ. Caveolae can be alternative endocytotic structures in elicited macrophages. Eur J Cell Biol 1997; 73(1):19-27.
88. Werling D, Hope JC, Chaplin P, et al. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol 1999; 66(1):50-58.
89. Anderson RG. The caveolae membrane system. Annu Rev Biochem 1998; 67:199-225.
90. Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68(4):673-682.
91. Schmid SL. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 1997; 66:511-548.
92. Brodsky FM, Chen CY, Knuehl C, et al. Biological basket weaving: formation and function of clathrin-coated vesicles. Annu Rev Cell Dev Biol 2001; 17:517-568.
93. Kirchhausen T. Clathrin. Annu Rev Biochem 2000; 69:699-727.
94. Anderson RG, Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 2002; 296(5574):1821-1825.
95. Edidin M. Membrane cholesterol, protein phosphorylation, and lipid rafts. Sci STKE 2001; 2001(67):E1.
96. Rothen-Rutishauser BM, Schurch S, Haenni B, et al. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 2006; 40(14):4353-4359.
97. Rimai DS, Quesnel DJ, Busnaia AA. The adhesion of dry particles in the nanometer to micrometer size range. Colloids Surf A Physicochem Eng Aspects 2000; 165:3-10.
98. Takenaka S, Karg E, Kreyling WG, et al. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006; 18(10):733-740.
99. Limbach LK, Li Y, Grass RN, et al. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 2005; 39(23):9370-9376.
100. Muhlfeld C, Rothen-Rutishauser B, Vanhecke D, et al. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol 2007; 4:11.
101. Rothen-Rutishauser B, Schurch S, Gehr P. Interaction of particles with membranes. In: Donaldson K, Borm P, ed. The Toxicology of Particles. Boca Raton, London and New York: CRC Press, 2007:139-160.
102. Kapp N, Kreyling W, Schulz H, et al. Electron energy loss spectroscopy for analysis of inhaled ultrafine particles in rat lungs. Microsc Res Tech 2004; 63(5):298-305.
103. Porter AE, Gass M, Muller K, et al. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomography. Environ Sci Technol 2007; 41(8): 3012-3017.
104. Li N, Sioutas C, Cho A, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003; 111(4):455-460.
105. Xia T, Korge P, Weiss JN, et al. Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ Health Perspect 2004; 112(14):1347-1358.
106. Gurr JR, Wang AS, Chen CH, et al. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 2005; 213(1-2):66-73.
107. Liu Y, Meyer-Zaika W, Franzka S, et al. Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires. Angew Chem Int Ed Engl 2003; 42(25): 2853-2857.
108. Tsoli M, Kuhn H, Brandau W, et al. Cellular uptake and toxicity of Au55 clusters. Small 2005; 1(8-9):841-844.